Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06073665 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dosing of LT4 in Older Individuals

Study acronym: DOT4
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 17 wordsv6 See this version in full on ClinicalTrials.gov ↗
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 1, 2024 to Jan 31, 2024 · Site details revisedv4 Show 2 more changesShow less
    • Start date changed from estimate of Feb 1, 2024 to Jan 31, 2024
    • Site details revised
  4. Start date: Nov 15, 2023 to Feb 1, 2024v3
  5. Start date: Oct 1, 2023 to Nov 15, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
Trial Details
NCT Number NCT06073665
Lead Sponsor University of Pennsylvania
Collaborators: National Institute on Aging (NIA)
Conditions Hypothyroidism
Enrollment 228 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov